US Patent No: 6,106,856

Number of patents in Portfolio can not be more than 2000

Transdermal delivery of calcium channel blockers, such as nifedipine

Stats

See full text
ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A transdermal formulation of dihydropyridine calcium antagonists and specifically nifedipine, nimodipine and nitrendipine. The calcium antagonists are dispersed in a mixed liquid. The mixed liquid comprises varying mole fractions of cis-oleic acid and dimethylisosorbide dispersed in a polypropylene glycol base.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
THE BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONSPROVIDENCE, RI130

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nanda, Anita San Diego, CA 1 1
Needham, Thomas E Wakefield, RI 4 88
Squillante, Emilio Coventry, RI 1 1
Zia, Hossein Wakefield, RI 2 17

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Godecke Aktiengesellschaft (1)
4,777,047 Transdermal application form of calcium antagonists 8 1986
 
LUZZI, LOUIS A. (1)
4,711,904 Method of treating skin disorders 7 1986
 
Warner-Lambert Company (1)
4,789,547 Transdermal matrix system 33 1987

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
KYUKYU PHARMACEUTICAL CO., LTD. (1)
6,906,043 Rapidly soluble film preparation 4 1998